PERFORMANCE / SINGLE
SERMORELIN
5MG · 10MGThis content is intended for educational and research reference only and does not constitute medical advice, diagnosis, or treatment. Experimental compounds are for research use only and are not for human consumption. Always consult qualified healthcare providers before starting any therapy.
Research Overview
A synthetic GHRH analogue studied for stimulating pulsatile endogenous growth-hormone release.
Available Strengths
- 5MG (SMO5)
- 10MG (SMO10)
Research Protocol
Reference gradual schedule
| Period | Dose | U-100 units | Volume |
|---|---|---|---|
| Weeks 1–2 | 0.2 mg | 12 | 0.12 mL |
| Weeks 3–4 | 0.3 mg | 18 | 0.18 mL |
| Weeks 5–6 | 0.4 mg | 24 | 0.24 mL |
| Weeks 7–8 | 0.5 mg | 30 | 0.3 mL |
Reconstitution
≈1.67 mg/mL once reconstituted
- Draw 3.0 mL of bacteriostatic water per 5 mg vial.
- Inject slowly along the vial wall; swirl gently until dissolved.
Research context
Stimulates GHRH receptors in the cited research while preserving physiological negative feedback, which the studies associate with a lower overdose risk than exogenous growth hormone.
Storage
2–8°C, dry and dark. 2–8°C, do not freeze; use within 10–14 days with bacteriostatic water.
Research Notes
- For educational and research reference only. Not medical advice and not intended for unsupervised human use.
References
Source reference: PeptideDosages.com · 2026-08-18 · Exact strength match with the cited source